MeSH D012640 - seizures
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009461:Neurologic manifestations
D012640:Â
Seizures
D000091323:Psychogenic nonepileptic seizures
0 Companies
0 Drugs
Success rate
D013226:Status epilepticus
D020270:Alcohol withdrawal seizures
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Accord Healthcare | Clobazam | Clobazam |  | 2019-05-23 |  |  |
| Pregabalin | Pregabalin Accord |  | 2015-08-28 |  |  | |
| ACI Healthcare | Pregabalin | Pregabalin |  | 2023-04-26 |  |  |
| Ajanta Pharma | Lamotrigine | Lamotrigine |  | 2021-01-19 |  |  |
| Alembic Pharmaceuticals | Lamotrigine | Lamotrigine |  | 2011-01-13 |  |  |
| Pregabalin | Pregabalin |  | 2019-07-19 |  |  | |
| Alkem Laboratories | Clobazam | Clobazam |  | 2019-09-06 |  |  |
| Lamotrigine | Lamotrigine |  | 2013-06-14 |  |  | |
| Pregabalin | Pregabalin |  | 2019-07-19 |  |  | |
| Rufinamide | Rufinamide |  | 2021-02-23 |  |  | |
| Allergan | Lamotrigine | Lamotrigine |  | 2009-01-22 |  |  |
| Folic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Ergocalciferol, Vitamin a, Biotin, Niacinamide, Pyridoxine, Riboflavin, Thiamine | Mvc |  | 1985-08-08 |  |  | |
| Pregabalin | Pregabalin |  | 2020-07-09 |  |  | |
| Alvogen | Pregabalin | Pregabalin |  | 2021-04-13 |  |  |
| American Regent | Fosphenytoin | Fosphenytoin |  | 2007-08-06 |  |  |
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
100%17/17
Phase 2
50%17/34
Phase 3
69%29/42
Approved: 14Overall Success rate: 35%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
7
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use